Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors

Transplantation. 1996 Jun 15;61(11):1659-60. doi: 10.1097/00007890-199606150-00022.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / drug therapy*
  • Ganciclovir / therapeutic use*
  • Humans
  • Liver Transplantation*
  • Phosphoproteins / blood*
  • Tissue Donors
  • Viral Matrix Proteins / blood*

Substances

  • Antiviral Agents
  • Phosphoproteins
  • Viral Matrix Proteins
  • cytomegalovirus matrix protein 65kDa
  • Ganciclovir